This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marty, C.
Right arrow Articles by Ye, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marty, C.
Right arrow Articles by Ye, R. D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2006, p. 5190-5200, Vol. 26, No. 13
0270-7306/06/$08.00+0     doi:10.1128/MCB.01979-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Activation State-Dependent Interaction between G{alpha}i and p67phox

Caroline Marty,1 Tohru Kozasa,1 Mark T. Quinn,2 and Richard D. Ye1*

Department of Pharmacology, College of Medicine, University of Illinois, Chicago, Illinois 60612,1 Department of Veterinary Molecular Biology, Montana State University, Bozeman, Montana 597172

Received 10 October 2005/ Returned for modification 3 November 2005/ Accepted 13 April 2006


arrow
ABSTRACT
 
The phagocyte NADPH oxidase consists of multiple protein subunits that interact with each other to form a functional superoxide-generating complex. Although the essential components for superoxide production have been well characterized, other proteins potentially involved in the regulation of NADPH oxidase activation remain to be identified. We report here that the G{alpha}i subunit of heterotrimeric G proteins is a novel binding partner for p67phox in transfected HEK293T cells and peripheral blood polymorphonuclear leukocytes. p67phox preferably interacted with inactive G{alpha}i. Expression of p67phox caused a dose-dependent decrease in intracellular cyclic AMP concentration, suggesting altered function of G{alpha}i. We identified a fragment of p67phox, consisting of the PB1 domain and the C-terminal SH3 domain, to be critical for the interaction with G{alpha}i. Because these domains are involved in the interaction with p47phox and p40phox, the relationship between the respective binding events was investigated. Wild-type G{alpha}i, but not its QL mutant, could promote the interaction between p67phox and p47phox. However, the interaction between p67phox and p40phox was not affected by either G{alpha}i form. These results provide the first evidence for an interaction between p67phox and an alpha subunit of heterotrimeric G proteins, suggesting a potential role for G{alpha}i in the regulation or activation of NADPH oxidase.


arrow
INTRODUCTION
 
Professional phagocytes play a critical role in the innate immune response to pathogens. The detection of microbial products such as fMet-Leu-Phe (fMLF) by resting neutrophils is an essential activating event that results in a spectrum of activities aimed to eliminate the causes of infection. In particular, neutrophils have the ability to generate toxic oxygen intermediates via activation of the NADPH oxidase (2), a tightly regulated multiprotein enzyme complex (32). Numerous studies have established that the active oxidase is composed of at least five essential subunits: membrane-associated gp91phox and p22phox, which form the redox core flavocytochrome b558 of the enzyme, and the cytosolic factors p67phox, p47phox, and p40phox (23, 29, 42, 43). Membrane translocation of the cytosolic subunits together with the active monomeric G protein Rac1/2 is a crucial step for assembly of a fully functional enzyme (1, 17).

p67phox is a multidomain protein implicated in essential NADPH oxidase protein-protein interactions. Its activation domain binds to the catalytic core of gp91phox and activates the electron transfer process (7, 27). The stretch of tetratricopeptide repeat (TPR) motifs in its amino terminus is responsible for recruitment of active Rac (19). The phox and bem1 (PB1) domain binds p40phox (12), and the C-terminal Src-homology 3 (SH3) sequence is necessary for association with p47phox (9). Therefore, p67phox appears as a central coordinator for NADPH oxidase assembly.

Chemoattractants such as fMLF stimulate G protein-coupled receptors, leading ultimately to O2 generation. The majority of signals arising from the chemoattractant receptors are pertussis toxin sensitive and therefore mediated by Gi proteins (5, 46). Moreover, it is the Gß{gamma} dimer that regulates a variety of effectors, such as phosphatidylinositol 3-kinase, phospholipase C-ß, and most likely specific Rac guanine nucleotide exchange factors, leading to oxidase activation. The G{alpha}i subunit, however, has not been implicated in the assembly or regulation of the NADPH oxidase.

Recent studies have led to the identification of several novel binding partners for G{alpha} proteins besides the conventional Gß{gamma}, downstream effectors, and specific G protein-coupled receptors. With a few exceptions, these proteins fall mainly into two defined groups: the regulators of G protein signaling (RGS) and the G{alpha}i/o-Loco (GoLoco)-containing proteins. RGS proteins attenuate G protein signaling by accelerating the intrinsic GTPase activity in G{alpha} (8, 36). The GoLoco interaction motif is found in a variety of proteins, such as activators of G protein signaling (AGS), Leu-Gly-Asn repeat-enriched protein (LGN), Pcp2, Rap1GAP, and others (20, 25). GoLoco proteins interact with GDP-bound G{alpha}i and act as guanine nucleotide dissociation inhibitors while impeding binding of Gß{gamma} (44). Of particular interest is the R12 class of RGS, comprising RGS10, 12, and 14, which possess both the characteristic RGS box and GoLoco domains in their sequences (16).

In the present study, we investigated whether p67phox could interact with the alpha subunits of heterotrimeric G proteins, because p67phox was previously shown to bind the small GTPase Rac (19, 22). We show that p67phox directly interacts with GDP-bound G{alpha}i in both transfected cells and human neutrophils. The binding site for G{alpha}i was localized to the C-terminal SH3 domain on p67phox. Overexpression of p67phox in our system dose dependently decreased basal levels of cyclic AMP (cAMP), a readout for activation of G{alpha}i signaling and also a negative regulator of O2 production. Furthermore, the association of p47phox with p67phox was affected by the G{alpha}i activation state, suggesting that G{alpha}i not only is a binding partner of p67phox but also may participate in the regulation of NADPH oxidase activation.


arrow
MATERIALS AND METHODS
 
Antibodies. Monoclonal antibody to c-MYC was purchased from Covance (Berkeley, CA) and that to FLAG from Sigma-Aldrich (St. Louis, MO). The anti-p67phox monoclonal antibody was from BD Transduction Laboratories (Lexington, KY). Antibodies specific to G{alpha}i1 and G{alpha}i3 were from Santa Cruz Biotechnology (Santa Cruz, CA), as were the anti-p47phox polyclonal and the anti-ß-actin monoclonal antibodies. The anti-G{alpha}i2 serum was produced in a rabbit (with amino acids 213 to 354 as an antigen), as was the anti-p67phox serum (raised against the purified glutathione S-transferase [GST]-p67phox fusion protein). The anti-p40phox polyclonal antibody was acquired from Upstate (Lake Placid, NY). Monoclonal antibodies were used at a concentration of 1 µg/ml and sera at a 1:1,000 dilution for Western blotting.

Culture and transient transfection of mammalian cells. The human embryonic kidney epithelial cell line 293T (HEK293T) was maintained in RPMI 1640 medium (Life Technologies) supplemented with 10% fetal bovine serum (FBS) and antibiotics (2 mM L-glutamine, 100 IU/ml penicillin, and 50 µg/ml streptomycin). Cells were transfected using LipofectAMINE Plus (Life Technologies) according to the manufacturer's instructions. For superoxide generation experiments, the monkey kidney epithelial transgenic COS-phox cells were maintained in Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 10% FBS and in the presence of 0.2 mg/ml hygromycin (Sigma), 0.8 mg/ml neomycin sulfate (Invitrogen), and 1 µg/ml puromycin (Calbiochem). Cells were transiently transfected using LipofectAMINE 2000 reagent (Life Technologies) according to the manufacturer's protocol.

Immunoprecipitation and Western blotting. Twenty-four hours after transfection, the cells were lysed in buffer containing 20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 1% Triton X-100, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 1x protease inhibitor cocktail set I (Calbiochem). For immunoprecipitation studies, the cleared lysates were incubated overnight at 4°C with either the MYC-specific monoclonal antibody (10 µg/ml), anti-G{alpha}i2 (1:250), or anti-p47phox (1 µg/ml) as indicated. Protein A/G PLUS-agarose (Santa Cruz Biotechnology) was added to the samples, and samples were incubated for 1.5 h at 4°C. The beads were washed and resuspended in 50 µl of 5x sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer and boiled for 5 min to release bound proteins. The resolved samples were detected by Western blotting. When working with human neutrophils (107 cells/sample), the same fractionating protocol was followed with minor modifications. Briefly, lysis was achieved in the presence of 2x protease inhibitor cocktail set I and 100 µM E-64 (Sigma). Lysis, immunoprecipitation, and washing were performed in the presence of 10 µM GDP or 10 µM GDP, 30 µM AlCl3, and 10 mM NaF (AMF).

Electrophoresis of the proteins on a 10% SDS-polyacrylamide gel was followed with transfer to a nitrocellulose membrane (Schleicher & Schuell). The blots were blocked with 5% nonfat dry milk in Tris-buffered saline-Tween buffer (20 mM Tris-HCl, pH 7.6, 137 mM NaCl, 0.1% Tween 20), washed, and incubated with primary antibodies overnight at 4°C. Anti-rabbit (Bio-Rad) or anti-mouse (Calbiochem) peroxidase-conjugated secondary antibodies were added to the membranes at a 1:3,000 dilution for 1 h at room temperature. The bands on the blots were visualized by chemiluminescence (Pierce).

Preparation of human neutrophils. Blood from healthy donors was collected following a procedure approved by the Institutional Review Board at the University of Illinois at Chicago by using ACD buffer (1.365% citric acid, 2.5% sodium citrate, and 2% dextrose). Erythrocytes were removed by sedimentation with Hespan (6% hetastarch; Abbott Laboratories). Polymorphonuclear leukocytes were further fractionated by centrifugation at 450 x g for 1 h at 12°C on a discontinuous Percoll (Amersham Pharmacia Biotech) gradient (74% and 55%). In a routine preparation, approximately 97% of the cells were neutrophils and the viability was about 98%, as determined by Trypan blue exclusion.

Expression and purification of recombinant GST fusion proteins in Escherichia coli and pulldown assay. The pGEX-2T and pGEX-p67phox constructs, encoding GST and full-length GST-p67phox fusion proteins, respectively, were introduced into the E. coli strain DH10B. Protein expression was induced with 0.1 mM isopropyl-1-thio-ß-D-galactopyranoside for 2 h at 30°C for GST-p67phox and 37°C for GST. The bacterial pellet was resuspended in 50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mg/ml lysozyme, 1x protease inhibitor cocktail set II (Calbiochem), and 2 mM dithiothreitol and sonicated. The lysate was complemented with 1% Triton X-100 and shaken for 1 h at 4°C. After centrifugation at 12,000 x g for 10 min at 4°C, the supernatant was snap-frozen for storage in 10% glycerol.

In vitro binding assay. Rat G{alpha}i1 purified from Sf9 cells was preloaded with either 30 µM GDP, 10 µM GTP{gamma}S (guanosine 5'-[{gamma}-thio] triphosphate), or AMF with 30 µM GDP in a buffer containing 20 mM HEPES, pH 8.0, 5 mM MgCl2, 1 mM EDTA, 0.05% Lubrol, and 1 mM dithiothreitol for 1 h at 30°C. The G{alpha}i cycle was stopped by the addition of 10 mM MgCl2. The binding between 1 µM GST fusion proteins coupled to glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech) and 0.025 µM preloaded G{alpha}i1 was performed in 100 µl of binding buffer (20 mM Tris-HCl, pH 8.0, 0.3 M NaCl, 10 mM MgCl2, 1 mM EDTA, 0.1% Lubrol, 10 mM ß-mercaptoethanol) supplemented with either GDP, GTP{gamma}S, or AMF where indicated for 2 h at 4°C. Beads were pelleted at 600 x g for 1 min at 4°C. The "unbound" fraction was recovered from the supernatant. Bound proteins were then eluted in 10 µl of 10 mM glutathione for 15 min at room temperature, 30 µl of 5x SDS-PAGE loading buffer was added to the eluate, and proteins were boiled for 10 min.

cAMP assay. Cells cultured in six-well plates were transfected, allowed to recover in 10% FBS-containing culture medium for 2.5 h, and starved overnight in Dulbecco's modified Eagle's medium without serum. cAMP accumulated in the presence of 1 mM isobutylmethylxanthine for 1 h at 37°C was measured using an enzyme-linked immunosorbent assay according to the manufacturer's protocol (Biomol, Pennsylvania).

Measure of NADPH oxidase activity. Superoxide production was determined using a chemiluminescence (CL) assay, as previously described (6). Briefly, COS-phox cells were collected with enzyme-free cell dissociation buffer (Invitrogen) and resuspended in 0.5% bovine serum albumin in Hanks' balanced salt solution with Ca2+ and Mg2+ at 3 x 106 to 5 x 106 cells/ml. Cells were incubated with 100 µM isoluminol (Sigma) and 40 U/ml horseradish peroxidase (Roche), and 200-µl aliquots were transferred into a white 96-well flat-bottom tissue culture plate (E&K Scientific). Chemiluminescence (count per second [cps]) was continuously assayed by using a Wallac 1420 multilabel counter plate reader (PerkinElmer) for 10 min before and 40 min after stimulation with either 1 µM fMLF (Sigma) or 200 ng/ml phorbol myristate acetate (PMA; Sigma). CL was integrated for 30 min after stimulation to show the relative levels of superoxide generated.


arrow
RESULTS
 
The interaction between G{alpha}i2 and p67phox is direct and depends on the G{alpha} activation state. To evaluate the potential interaction of p67phox and G{alpha}i, an expression construct was created to produce C-terminal MYC-tagged p67phox (p67phox-MYC). Moreover, activity of recombinant p67phox-MYC was verified in a whole cell-based reconstitution assay, which required exogenous p67phox for fMLF- and PMA-induced O2 generation (11). The p67phox-MYC DNA construct was transiently cotransfected with vectors encoding each of the three isoforms of G{alpha}i into HEK293T cells, which do not express any of the NADPH oxidase components except for Rac1. Both inactive wild-type G{alpha}i (G{alpha}iwt) and the GTPase-deficient (constitutively active) G{alpha}i mutants (Q204L for G{alpha}i1 and G{alpha}i3 and Q205L for G{alpha}i2) were examined. Twenty-four hours after transfection, p67phox-MYC was immunoprecipitated from cell lysates, and the precipitates were analyzed by immunoblotting. Surprisingly, G{alpha}i1wt, G{alpha}i2wt, and G{alpha}i3wt were all detected in the immunoprecipitates (Fig. 1). Additionally, we also observed a modest interaction between p67phox and the endogenous G{alpha}i (vector, mock-transfected cells). Interestingly, the interaction between p67phox and the active G{alpha}iQL was significantly reduced to levels as low as or even below those of the vector controls (Fig. 1A, lanes 3 versus lanes 1). The specificity of this interaction was validated by the observation that neither the GDP- nor the GTP-bound forms of G{alpha}s could associate with p67phox (data not shown).


Figure 1
View larger version (40K):
[in this window]
[in a new window]
 
FIG. 1. In vivo interaction between G{alpha}i and p67phox. (A) HEK293T cells were transiently transfected with DNA encoding a C-terminal MYC-tagged p67phox protein either alone (Vector) or together with individual expression vector encoding the inactive form (wt) or GTPase-deficient mutant (QL) of the three isoforms G{alpha}i1, G{alpha}i2, and G{alpha}i3, as indicated. Cell lysates were immunoprecipitated with an anti-MYC MAb. Immunoprecipitates (IP, top panels) and cell homogenates (bottom panels) were analyzed by Western blotting (IB) with the respective specific anti-G{alpha}i sera. p67phox-MYC in the IP serves as a loading control (middle panels). In the absence of p67phox-MYC, none of the G{alpha}i are detectable in the IP fractions (not shown). (B) Human neutrophils were isolated from peripheral blood as described in Materials and Methods. Cells were treated with 1 µM fMLF for 5 min at 37°C or not treated. Cell lysis and immunoprecipitation with an anti-G{alpha}i2 serum were conducted in the absence or presence of AMF. The ability of endogenous p67phox to bind to G{alpha}i2 was assessed by blotting (IB) the immunoprecipitates (IP) with an anti-p67phox MAb (top panel). Levels of p67phox and G{alpha}i2 expression in neutrophils were detected in homogenates (two bottom panels). G{alpha}i2 in the IP serves as a loading control (second panel from top). Data shown are representative of a typical experiment.

Since the resting and activated NADPH oxidase states are tightly regulated by complex protein-protein interactions (35), we examined whether the binding between p67phox and G{alpha}i could occur in the presence of the other NADPH components in an environment where the enzyme is fully functional. We isolated neutrophils from human peripheral blood, lysed them, and immunoprecipitated endogenously expressed G{alpha}i2 in the absence or presence of AMF, which mimics the transition state of GTP hydrolysis. As expected from the previous observations, an interaction between p67phox and G{alpha}i2 was detectable in nontreated cell lysates and was markedly diminished in the presence of AMF (Fig. 1B, lane 2 versus lane 1). Since fMLF stimulates neutrophil O2 production via activation of the Gi proteins, we treated isolated neutrophils with 1 µM fMLF before lysis and immunoprecipitation with an anti-G{alpha}i2 serum. In this case too, the interaction between the endogenous p67phox and G{alpha}i2 was markedly decreased compared to that observed in unstimulated neutrophils (Fig. 1B, lane 3 versus lane 1). Thus, the binding of p67phox with G{alpha}i2 is dependent on the G protein activation state and is observed in resting neutrophils.

To further investigate whether this interaction was direct, we performed an in vitro binding assay between purified, bacterially expressed GST-p67phox and Sf9-expressed G{alpha}i1 (Fig. 2). The GST-p67phox fusion protein coupled to glutathione-Sepharose beads, but not the GST control protein, specifically bound G{alpha}i1 in the presence of GDP but not when the G{alpha}i was preloaded with either AMF or GTP{gamma}S. Thus, these data demonstrate a direct interaction between p67phox and G{alpha}i and again show that the interaction is modulated by the G{alpha}i activation state.


Figure 2
View larger version (26K):
[in this window]
[in a new window]
 
FIG. 2. Direct interaction between G{alpha}i1 and p67phox in vitro. Binding between 100 pmol of purified bacterially expressed GST or GST-p67phox fusion protein immobilized on glutathione-Sepharose beads and 2.5 pmol of purified G{alpha}i1 preloaded with either GDP, AMF, or GTP{gamma}S was assayed as described in Materials and Methods. Bound proteins were eluted, resolved by 10% polyacrylamide SDS-PAGE, and analyzed by blotting with an anti-G{alpha}i1 serum (top panel). G{alpha}i1 input was verified in each sample (middle panel), and both GST and GST-p67phox used for the pulldown were detected with Coomassie blue staining and served as a loading control (bottom panel). Blots shown are representative of a typical experiment.

Expression of p67phox partially inhibits cAMP formation. Activation of the G{alpha}i family of G proteins is responsible for the inhibition of adenylyl cyclase and subsequent reduction in the basal and inducible levels of cAMP. To gain an insight into a potential role of p67phox in the G{alpha}i activation/inactivation cycle in a receptor-independent manner, we examined the effect of p67phox on the G{alpha}i-mediated cAMP basal level. In HEK293T cells transfected to express increasing amounts of untagged p67phox, cAMP production was dose dependently inhibited (Fig. 3A), with a 50% reduction at the highest DNA concentration used for transfection. As a control, similar amounts of a vector encoding AGS3 did not influence the cAMP level (data not shown).


Figure 3
View larger version (31K):
[in this window]
[in a new window]
 
FIG. 3. Dose-dependent effect of p67phox on G{alpha}i activity and interaction with Gß{gamma}. (A) Accumulated cAMP levels were measured in vector- versus p67phox-transfected HEK293T cells. Increasing levels of p67phox expression and equivalent amounts of endogenous G{alpha}i2 in each sample were determined by immunoblotting with the respective antisera. Values for cAMP concentration were expressed as a percentage relative to the basal level (vector), which was assigned a value of 100%. The histograms show the means ± standard errors of the means of triplicate experiments (n = 3). Student's t test was used to compare the significance of the decrease to the basal level (*, P < 0.01; **, P < 0.001). (B) FLAG-tagged Gß1 and G{gamma}2 were coexpressed alone (Vector) and either with G{alpha}i2wt or in combination with G{alpha}i2wt and two different concentrations of p67phox-MYC as indicated. Cell homogenates were subjected to immunoprecipitation (IP) with an anti-FLAG MAb. The integrity of G{alpha}i/Gß{gamma} interaction was verified by blotting the immunoprecipitates with an anti-G{alpha}i2 serum (top panel). The homogenates were analyzed for protein expression (two bottom panels), and total FLAG-Gß1 in the immunoprecipitates serves as a loading control (middle panel). (C) HEK293T cells were transiently transfected to express a C-terminal MYC-tagged p67phox either alone (Vector) or with Gß1 and G{gamma}2 in the absence or presence of exogenous wild-type G{alpha}i2, which directly interacts with Gß{gamma}. The cell homogenates were subjected to immunoprecipitation using an anti-MYC MAb and analyzed by Western blotting (IB). Blots shown were reproduced in three independent experiments.

Heterotrimeric G proteins are composed of the guanine nucleotide-binding G{alpha} subunit and the Gß{gamma} dimer, which are regarded as one functional unit. G proteins are inactive in the GDP-bound state. Since p67phox preferentially binds to inactive G{alpha}i, we expected that it might compete with Gß{gamma} for association with GDP-bound G{alpha}i. Surprisingly, in transiently transfected HEK293T cells, increasing amounts of p67phox-MYC did not disrupt the interaction between Gß1{gamma}2 and G{alpha}i (Fig. 3B). These observations suggest that p67phox most likely binds to G{alpha}i on a site distinct from the Gß{gamma} contact surface. Indeed, overexpression of p67phox showed no effect on the basal phosphorylation of Akt, a characterized readout for Gß{gamma} activation (data not shown). Finally, we verified that the ability of Gß{gamma} to coimmunoprecipitate p67phox was mediated by the inactive G{alpha}i (Fig. 3C). Indeed, FLAG-tagged Gß1 was found to bind to p67phox only when G{alpha}i2 was overexpressed in the cells. Endogenous G{alpha}i appeared to be insufficient to mediate the association between FLAG-Gß1 and p67phox-MYC, most likely because it already forms heterotrimers with endogenous Gß{gamma} proteins, which cannot be detected with the anti-FLAG monoclonal antibody (MAb). Based on these data, we concluded that the association between Gß{gamma} and p67phox is indirect and mediated through the inactive, GDP-bound G{alpha}i.

Determination of G{alpha}i binding site on p67phox. p67phox is a multidomain protein (Fig. 4A). The N-terminal TPR domain (amino acids 3 to 154) is composed of four TPR motifs and directly binds Rac-GTP (19, 22). This segment (amino acids 1 to 199) was also demonstrated to mediate direct interaction with gp91phox (7). A short activation domain (amino acids 199 to 210) immediately follows the TPR domain (27), and the C-terminal segment contains two SH3 modules flanking a PB1 domain. The PB1 and C-terminal SH3 domains are involved in the direct interactions with p40phox and p47phox, respectively (9, 12). In an attempt to localize the region of p67phox required for G{alpha}i binding, a series of truncated MYC-tagged p67phox mutants was generated (Fig. 4A), verified by sequencing, and separately expressed into HEK293T cells together with G{alpha}i2wt (Fig. 4B). In immunoprecipitation and immunoblotting experiments, the p67phox C-terminal fragment (amino acids 213 to 526) precipitated G{alpha}i2 as effectively as did full-length p67phox, whereas the N-terminal segment (amino acids 1 to 213) did not retain binding to the G{alpha} protein (Fig. 4B, lanes 2 and 3 versus lane 1). Furthermore, the fragment covering residues 340 to 526 was shown to be sufficient for interaction with G{alpha}i2, whereas the sequence extending from amino acids 303 to 455 did not bind G{alpha}i2. Therefore, at first view the C-terminal SH3 was the most likely candidate for the G{alpha}i binding site, and two additional p67phox mutants that both contained PB1, p67phox(1-430)-MYC and p67phox{Delta}(460-515)-MYC, seemed to confirm this conclusion. However, the C-terminal SH3 and its flanking regions (residues 429 to 526) failed to coimmunoprecipitate G{alpha}i2. Therefore, the C-terminal SH3 in p67phox could be necessary but not sufficient for recruitment of G{alpha}i, and perhaps both PB1 and the second SH3 in p67phox contribute to the binding interaction with G{alpha}i.


Figure 4
View larger version (32K):
[in this window]
[in a new window]
 
FIG. 4. Identification of G{alpha}i2 binding site on p67phox. (A) Schematic representation of full-length p67phox and the truncated mutants generated. All proteins were MYC tagged at either the N or the C terminus. AD, activation domain; PR, proline-rich region; SH3, Src-homology 3 domain; PB1, phox and bem1 domain. (B) The full-length p67phox and deletion p67phox mutants were overexpressed in HEK293T cells together with G{alpha}i2wt. Cell lysates were precipitated with anti-MYC MAb. Western blotting (IB) of the immunoprecipitates (IP) with an anti-p67phox serum, generated against the full-length protein, identified proper expression of the various constructs and served as a loading control (middle panel). The ability of the mutants to retain G{alpha}i2wt binding was examined by blotting the IP with the anti-G{alpha}i2 serum (top panel). Equal levels of G{alpha}i2 expression were assessed by probing the cell homogenates with the anti-G{alpha}i2 serum (bottom panel). Data shown were reproduced in at least three independent experiments.

The interaction between p47phox and p67phox but not between p40phox and p67phox is dependent on the G{alpha}i activation state. Since the C-terminal SH3 domain of p67phox can interact directly with p47phox and its PB1 domain associates with the phox and Cdc (PC) domain of p40phox (9, 12), we investigated whether G{alpha}i2 overexpression could influence these binding interactions. p67phox and p47phox were coexpressed in HEK293T cells together with G{alpha}i2 (Fig. 5A). Interestingly, the wild type but not the GTPase-deficient mutant of G{alpha}i2 increased the interaction between p67phox and p47phox (Fig. 5A, top panel, lanes 4 and 5 versus lane 3). However, in the presence of p47phox the association between p67phox and G{alpha}i2 was barely detectable (Fig. 5A, second panel from top, compare lanes 4 and 5 to lanes 1 and 2). This finding suggests that p47phox competes with G{alpha}i for binding to p67phox.


Figure 5
View larger version (35K):
[in this window]
[in a new window]
 
FIG. 5. Effect of G{alpha}i2 activation state on p47phox and p40phox interactions with p67phox. (A) The p67phox-MYC protein was transiently expressed in HEK293T cells in combination with the NADPH oxidase component p47phox and/or G{alpha}i2 as indicated. The cell homogenates were subjected to immunoprecipitation with anti-MYC MAb and analyzed by Western blotting. Total p67phox-MYC in the precipitates (IP) was shown by probing the blot (IB) with an anti-MYC MAb (middle panel). The IP (two upper panels) and cell homogenates (two lower panels) were probed with an anti-p47phox polyclonal Ab and an anti-G{alpha}i2 serum for the ability to coimmunoprecipitate with p67phox-MYC and for their expression in the cells. The same experiment was performed with p40phox instead of p47phox (B) and with both p47phox and p40phox together (C). Results are representative of at least three independent experiments.

Similar experiments were conducted in cells expressing p67phox, G{alpha}i2, and p40phox (Fig. 5B). The interaction between p67phox and p40phox was not affected by the expression of either G{alpha}i2wt or G{alpha}i2QL (Fig. 5B, top panel, lanes 3, 4, and 5). Surprisingly, p67phox, which preferentially binds to inactive G{alpha}i in the absence of p40phox, switched its affinity for the active form of the G{alpha}i protein when p40phox was present (Fig. 5B, second panel from top, lanes 1 and 2 compared to lanes 4 and 5). The decreased but still apparent coimmunoprecipitation between p67phox and inactive G{alpha}i in the presence of p40phox suggests that p40phox might only partially displace G{alpha}i from p67phox.

Finally, all four binding partners were coexpressed together (Fig. 5C). Interestingly, in the presence of both p47phox and p40phox, the characteristic difference in p67phox binding to G{alpha}i2wt versus G{alpha}i2QL remained (Fig. 5C, top panel, lanes 4 and 5 versus lanes 2 and 3). Taken together, these data confirm the delicate dynamics in protein-protein interactions involved in the formation and regulation of p67phox-containing complexes.

The phox components p67phox and p47phox associate with G{alpha}i in one large complex. In HEK293T cells and in the absence of p40phox, p47phox was found to completely block the binding of G{alpha}i2 to p67phox (Fig. 5A). However, when the three phox proteins and G{alpha}i2 were coexpressed, as a closer mimic of human neutrophils, both p47phox and G{alpha}i2 coimmunoprecipitated with MYC-tagged p67phox (Fig. 5C). Therefore, we tested whether p67phox, p47phox, and G{alpha}i2 would associate in the same large complex or bind differently to form a variety of smaller ones. Human neutrophils were purified from peripheral blood and either unstimulated or stimulated with 1 µM fMLF before lysis and immunoprecipitation with antibodies against p47phox and G{alpha}i2 (Fig. 6). Both G{alpha}i2 and p67phox were detected in the anti-p47phox precipitates in either resting or fMLF-stimulated cells. Similarly, both p47phox and p67phox coimmunoprecipitated with G{alpha}i2. Interestingly, the interaction between p47phox and p67phox increased upon fMLF stimulation, with G{alpha}i2 concomitantly dissociating from the complex (Fig. 6, "IP: p47phox" set of panels). As expected, p67phox interaction with G{alpha}i2 markedly diminished after fMLF treatment and so did the association between p47phox and G{alpha}i2 (Fig. 6, "IP: G{alpha}i2" set of panels). p67phox most likely bridges p47phox and G{alpha}i2, causing them to coimmunoprecipitate. Indeed, we have not observed any interaction between G{alpha}i2 and p47phox in the absence of p67phox in HEK293T cells (data not shown). Taken together, these results support the presence of a multiprotein complex containing p47phox, G{alpha}i, and p67phox.


Figure 6
View larger version (38K):
[in this window]
[in a new window]
 
FIG. 6. Association of G{alpha}i2, p67phox, and p47phox in one large complex. Purified human neutrophils were either unstimulated or stimulated with 1 µM fMLF for 5 min and lysed. Proteins from cell homogenates were precipitated (IP) with either an anti-p47phox polyclonal antibody or an anti-G{alpha}i2 serum, followed by Western blotting (IB) using specific antibodies against each component as indicated. The expression levels in neutrophils of the three proteins were detected by probing the homogenates with the respective antibodies (panels on the right side). Data are representative of similar results obtained in three independent experiments.

Functional implications of G{alpha}i interaction with p67phox on NADPH oxidase activity. We took advantage of the COS-phox system, a whole-cell-based reconstitution assay manipulated to generate fMLF-induced O2 (11, 31). The transgenic cells stably expressing gp91phox, p22phox, p67phox, and p47phox were transiently transfected with DNA coding for the formyl peptide receptor (FPR), as well as protein kinase C{delta} (PKC{delta}) and p40phox, both being highly abundant in neutrophils but scarce in COS7 cells. Where indicated, G{alpha}i2 was overexpressed in the cells. We verified by Western blotting that exogenous G{alpha}i2 did not affect the relative levels of expression of any of the three cytosolic phox components (Fig. 7C). The transfected cells were then challenged with either 1 µM fMLF (Fig. 7A, left graph) or 200 ng/ml PMA (Fig. 7A, right graph), and the produced O2 was measured by isoluminol-dependent chemiluminescence. PMA is a PKC agonist that bypasses activation of Gi to stimulate NADPH oxidase activity. Interestingly, overexpression of G{alpha}i2 increased both fMLF- and PMA-induced O2 generation (Fig. 7A and B). Although promotion of fMLF-stimulated O2 production might be due in part to the availability of more G{alpha}i for FPR, the increase in O2 generated by PMA stimulation indicates that G{alpha}i possibly plays a positive regulatory role in NADPH oxidase activation.


Figure 7
View larger version (30K):
[in this window]
[in a new window]
 
FIG. 7. Functional relevance of G{alpha}i overexpression in NADPH oxidase activity. COS-phox cells were transiently transfected with vectors coding for FPR, PKC{delta}, and p40phox in the absence or presence of overexpressed G{alpha}i2. (A) Cells were stimulated with either 1 µM fMLF (left panel) or 200 ng/ml PMA (right panel), as indicated by the black arrow, and monitored for O2 generation. (B) Histograms showing CL integrated for 30 min after stimulation as means ± standard deviations of two independent experiments performed in duplicate. (C) Western blots indicating expression of G{alpha}i2, p40phox, and the stably expressed p67phox and p47phox in COS-phox cells transfected with DNA encoding G{alpha}i2 or not transfected, using specific antibodies. ß-Actin serves as a loading control.


arrow
DISCUSSION
 
In phagocytic cells, functional assembly of the NADPH oxidase in the phagosome and plasma membrane is a rapid and complex process and is essential for host defense against pathogens (32). Chemoattractant-induced O2 generation is mediated through Gß{gamma} originating from activation of heterotrimeric Gi proteins (5). However, it is unclear whether the G{alpha}i proteins also play a role in NADPH oxidase activation through a different mechanism. A major finding of this study is the identification of GDP-bound G{alpha}i as a direct p67phox binding partner. To our knowledge, this is the first report that suggests a potential role for G{alpha}i in oxidase enzyme assembly and raises the possibility that G{alpha}i may be a distinct player in NADPH oxidase regulation.

Using coimmunoprecipitation and in vitro binding analysis, we observed an interaction between the inactive, GDP-bound G{alpha}i and the cytosolic factor p67phox. This binding exists not only in transiently transfected cells (Fig. 1A) but also, and more importantly, in human neutrophils (Fig. 1B). The interaction significantly decreases upon activation of G{alpha}i, suggesting that p67phox can recognize the conformational changes associated with G{alpha}i activation. Since p67phox does not appear to compete with Gß{gamma} for association with GDP-bound G{alpha}i (Fig. 3B), the binding site for p67phox on G{alpha}i must be different from the G{alpha}i/Gß{gamma} interface. Furthermore, there is no observable difference in G{alpha}i2 and p67phox coimmunoprecipitation between untreated and pertussis toxin-treated (500 ng/ml, 4 h) cells (data not shown), which irreversibly ADP-ribosylates a specific C-terminal cysteine residue on the G{alpha}i subunit that leads to uncoupling from the receptor. Thus, the C-terminal sequence of G{alpha}i does not appear to be involved in the interaction with p67phox.

The possible relationship between G{alpha}i and the three cytosolic factors of NADPH oxidase is depicted in Fig. 8. Analysis of the deletion mutants of p67phox revealed that the C-terminal SH3 motif of p67phox (Fig. 8A), previously characterized as a direct binding site for p47phox (9), also contributes to the recruitment of G{alpha}i (Fig. 4). Indeed, p47phox can fully compete inactive G{alpha}i off of p67phox (Fig. 5A). However, in neutrophils p67phox clearly binds better with inactive G{alpha}i (Fig. 1B), even in the presence of endogenous p40phox and p47phox. Moreover, G{alpha}i2, p47phox, and p67phox were found to associate in the same complex (Fig. 6). Therefore, we tested whether coexpression of p67phox, p47phox, and p40phox in HEK293T cells, together with G{alpha}i2, would mimic what we observed in neutrophils (Fig. 5C). Indeed, the preference of p67phox for inactive G{alpha}i2 is maintained in the presence of both p47phox and p40phox. In addition, the binding of p47phox and G{alpha}i2 to p67phox is no longer mutually exclusive in the presence of p40phox. Coimmunoprecipitation assays performed in neutrophils have confirmed the presence of a multisubunit complex containing p47phox, p67phox, and G{alpha}i2 (Fig. 6). However, it is possible that only subpopulations of p67phox and G{alpha}i are associated at a given time, and it is also likely that a variety of multimers coexists in the cell. Additionally, evidence suggesting that p67phox can homodimerize may support the observation that p47phox and G{alpha}i are both present in the same large complex with p67phox and most likely have overlapping binding sites on p67phox. Although the intriguing prospect that p67phox can homodimerize has been approached in only a few biochemical studies drawing contradictory conclusions (10, 21), we have observed homodimerization of p67phox in transfected HEK293T cells (data not shown). Taken together, these findings suggest the possibility that the p47phox- and G{alpha}i-containing complex may comprise two or more copies of p67phox.


Figure 8
View larger version (27K):
[in this window]
[in a new window]
 
FIG. 8. Model for the participation of G{alpha}i in interactions between NADPH oxidase components. (A) Linear representations of p47phox, p67phox, and p40phox. The C-terminal SH3 domain of p67phox interacts with the proline-rich (PR) region of p47phox, and the PB1 domain binds to the phox and cdc motif (PC) of p40phox. AD, activation domain; SH3, Src-homology 3 domain; PB1, phox and bem1 domain; PX, phox domain. (B) A potential role of G{alpha}i in targeting p67phox to specific subcellular compartments. Inactive G{alpha}i, tethered to either the membrane or the cytoskeleton, may position p67phox in close proximity to p47phox and promote their interaction. The association between the two phox proteins then competes G{alpha}i off of p67phox. (C) The recruitment of p40phox to p67phox is not significantly influenced by G{alpha}i. p40phox may only partially displace G{alpha}i from p67phox, allowing the formation of various complexes which may or may not include G{alpha}i. Based on our experimental results, we hypothesize that upon activation of the G protein an additional partner may be involved in the association between the active G{alpha}i and p67phox.

It is presently unclear how the binding of G{alpha}i to p67phox facilitates or influences assembly of the enzyme complex. One possibility is that this association promotes colocalization of the relevant interacting proteins in specific subcellular compartments, most likely in the cytosol or in the cytoskeletal fraction. Indeed, members of the large TPR-containing proteins, such as AGS3 (14, 30) and TPR1 (24), are emerging as novel adaptors and scaffolds for G protein signaling. A possible explanation for the increased interaction between p67phox and p47phox in the presence of the GDP-bound G{alpha}i is that this G protein, through its association with p67phox, positions p67phox in close proximity to p47phox, thereby facilitating p47phox-p67phox interaction (Fig. 8B). These interactions most likely occur within the cell, as both p67phox and p47phox are cytosolic factors, and their association precedes membrane translocation of the complex. Moreover, several groups have confirmed the presence of two distinct pools of G{alpha}i2, which are located in the plasma membrane and the cytosol fractions of unstimulated neutrophils (4, 15, 37, 38). Studies have also shown G{alpha}i binding to F-actin and tubulin in cytoplasmic structures and at the plasma membrane (34). The cytoskeleton provides a dynamic network between cellular structures and a docking surface for various signaling proteins, including G{alpha}i, in response to cell activation (13). Consistent with these observations, p67phox and p47phox are principally recovered in the cytoskeletal fraction of unstimulated and stimulated neutrophils (26, 41, 45). Thus, reorganized cytoskeleton may provide a scaffold for activation of the NADPH oxidase components in response to cell stimulation (33). Taken together with these previous observations, our findings support the hypothesis that the association between G{alpha}i and p67phox occurs in the cytosol of resting cells to favor the interaction between p67phox and p47phox, presumably involving the cytoskeleton. Upon stimulation, the readily mobilizable, preformed cytosolic phox complex can then translocate to the membrane for full assembly and activation of NADPH oxidase (18). Exactly how fMLF stimulation triggers activation of an intracellularly localized G{alpha}i has not been investigated. The availability of G{alpha}i as well as its activation state may also be influenced by multiple factors and regulated by fMLF. Indeed, Sarndahl et al. (39) showed activation and dissociation of cytoskeleton-bound G{alpha}i upon fMLF stimulation.

In addition to p67phox and p47phox, neutrophils contain p40phox, a cytosolic factor copurified with p67phox (40). The exact function of p40phox in promoting or inhibiting neutrophil NADPH oxidase assembly remains debatable. Interestingly, the addition of p40phox to our system causes a change in preference of p67phox from the inactive to the active form of G{alpha}i (Fig. 5B). However, in the presence of p47phox, this change is reverted (Fig. 5C). We speculate that under these conditions, p67phox, p47phox, and p40phox cooperate in a temporal and spatial manner to favor formation of the p67phox/GDP-bound G{alpha}i. The mechanism underlying this event is currently unknown and is a subject of our ongoing research. Based on data obtained from the in vitro binding assay with GTP{gamma}S-loaded G{alpha}i (Fig. 2), the coimmunoprecipitation between p67phox and the active form of G{alpha}i2 in the presence of p40phox is most likely indirect and may require an unidentified factor (Fig. 8C). Thus, the prospect of an additional cofactor(s) raises the order of complexity in the sequence of interactions that takes place in NADPH oxidase assembly.

The interaction between p67phox and G{alpha}i may functionally impact NADPH oxidase assembly and activation. In the intact COS-phox cell-based assay, overexpression of G{alpha}i2 promoted not only fMLF- but also PMA-stimulated O2 generation (Fig. 7). This observation supports the possibility that G{alpha}i interaction with p67phox facilitates the formation of the p67phox-p47phox cytosolic complex, which favors NADPH oxidase activation. Stimulation of the G{alpha}i-coupled FPR by fMLF not only activates G{alpha} but also makes Gß{gamma} available for its downstream effectors. Along with these events, the GTP-bound G{alpha}i can dissociate from p67phox (Fig. 6). Therefore, in activated cells, the increased binding between p47phox and p67phox and enhanced NADPH oxidase activity can be attributed to a combination of factors, including signals arising from Gß{gamma}. To our surprise, exogenous expression of p67phox dose dependently reduced cAMP basal levels in HEK293T cells, appearing as a positive regulator of the G{alpha}i signaling pathway (Fig. 3A). The cAMP-dependent protein kinase A is a characterized inhibitor of O2 production in inflammatory cells (3, 28). Although it is still unclear whether p67phox has an effect on cAMP in neutrophils, it is conceivable that a dampening of cAMP levels in neutrophils may contribute to priming for O2 generation. Given the ability of G{alpha}i-coupled receptors, such as the interleukin-8 receptor, to potentiate NADPH oxidase activation, the direct and activation state-dependent interaction between p67phox and G{alpha}i may represent another regulatory mechanism for NADPH oxidase activation.


arrow
ACKNOWLEDGMENTS
 
We thank Mary Dinauer for providing the COS-phox cells and Rong He for helpful discussions.

This work was supported by NIH grants AI033503, HL077806, GM066182, and AR042426.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Pharmacology, University of Illinois at Chicago, 835 S. Wolcott Avenue, Chicago, IL 60612. Phone: (312) 996-5087. Fax: (312) 996-7857. E-mail: yer{at}uic.edu. Back


arrow
REFERENCES
 
    1
  1. Abo, A., E. Pick, A. Hall, N. Totty, C. G. Teahan, and A. W. Segal. 1991. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353:668-670.[CrossRef][Medline]
  2. 2
  3. Babior, B. M., J. D. Lambeth, and W. Nauseef. 2002. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397:342-344.[CrossRef][Medline]
  4. 3
  5. Bengis-Garber, C., and N. Gruener. 1996. Protein kinase A downregulates the phosphorylation of p47 phox in human neutrophils: a possible pathway for inhibition of the respiratory burst. Cell. Signal. 8:291-296.[CrossRef][Medline]
  6. 4
  7. Bokoch, G. M., K. Bickford, and B. P. Bohl. 1988. Subcellular localization and quantitation of the major neutrophil pertussis toxin substrate, Gn. J. Cell Biol. 106:1927-1936.[Abstract/Free Full Text]
  8. 5
  9. Bokoch, G. M. 1995. Chemoattractant signaling and leukocyte activation. Blood 86:1649-1660.[Free Full Text]
  10. 6
  11. Dahlgren, C., and A. Karlsson. 1999. Respiratory burst in human neutrophils. J. Immunol. Methods 232:3-14.[CrossRef][Medline]
  12. 7
  13. Dang, P. M., A. R. Cross, M. T. Quinn, and B. M. Babior. 2002. Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558 II. Proc. Natl. Acad. Sci. USA 99:4262-4265.[Abstract/Free Full Text]
  14. 8
  15. De Vries, L., B. Zheng, T. Fischer, E. Elenko, and M. G. Farquhar. 2000. The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40:235-271.[CrossRef][Medline]
  16. 9
  17. Finan, P., Y. Shimizu, I. Gout, J. Hsuan, O. Truong, C. Butcher, P. Bennett, M. D. Waterfield, and S. Kellie. 1994. An SH3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J. Biol. Chem. 269:13752-13755.[Abstract/Free Full Text]
  18. 10
  19. Grizot, S., N. Grandvaux, F. Fieschi, J. Faure, C. Massenet, J. P. Andrieu, A. Fuchs, P. V. Vignais, P. A. Timmins, M. C. Dagher, and E. Pebay-Peyroula. 2001. Small angle neutron scattering and gel filtration analyses of neutrophil NADPH oxidase cytosolic factors highlight the role of the C-terminal end of p47phox in the association with p40phox. Biochemistry 40:3127-3133.[CrossRef][Medline]
  20. 11
  21. He, R., M. Nanamori, H. Sang, H. Yin, M. C. Dinauer, and R. D. Ye. 2004. Reconstitution of chemotactic peptide-induced nicotinamide adenine dinucleotide phosphate (reduced) oxidase activation in transgenic COS-phox cells. J. Immunol. 173:7462-7470.[Abstract/Free Full Text]
  22. 12
  23. Ito, T., Y. Matsui, T. Ago, K. Ota, and H. Sumimoto. 2001. Novel modular domain PB1 recognizes PC motif to mediate functional protein-protein interactions. EMBO J. 20:3938-3946.[CrossRef][Medline]
  24. 13
  25. Janmey, P. A. 1998. The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol. Rev. 78:763-781.[Abstract/Free Full Text]
  26. 14
  27. Kaushik, R., F. Yu, W. Chia, X. Yang, and S. Bahri. 2003. Subcellular localization of LGN during mitosis: evidence for its cortical localization in mitotic cell culture systems and its requirement for normal cell cycle progression. Mol. Biol. Cell 14:3144-3155.[Abstract/Free Full Text]
  28. 15
  29. Khachatrian, L., J. B. Rubins, E. C. Manning, D. Dexter, A. I. Tauber, and B. F. Dickey. 1990. Subcellular distribution and characterization of GTP-binding proteins in human neutrophils. Biochim. Biophys. Acta 1054:237-245.[Medline]
  30. 16
  31. Kimple, R. J., L. De Vries, H. Tronchere, C. I. Behe, R. A. Morris, M. Gist Farquhar, and D. P. Siderovski. 2001. RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction sites with guanine nucleotide dissociation inhibitor activity. J. Biol. Chem. 276:29275-29281.[Abstract/Free Full Text]
  32. 17
  33. Knaus, U. G., P. G. Heyworth, T. Evans, J. T. Curnutte, and G. M. Bokoch. 1991. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 254:1512-1515.[Abstract/Free Full Text]
  34. 18
  35. Kobayashi, T., S. Tsunawaki, and H. Seguchi. 2001. Evaluation of the process for superoxide production by NADPH oxidase in human neutrophils: evidence for cytoplasmic origin of superoxide. Redox Rep. 6:27-36.[CrossRef][Medline]
  36. 19
  37. Koga, H., H. Terasawa, H. Nunoi, K. Takeshige, F. Inagaki, and H. Sumimoto. 1999. Tetratricopeptide repeat (TPR) motifs of p67(phox) participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J. Biol. Chem. 274:25051-25060.[Abstract/Free Full Text]
  38. 20
  39. Lanier, S. M. 2004. AGS proteins, GPR motifs and the signals processed by heterotrimeric G proteins. Biol. Cell 96:369-372.[CrossRef][Medline]
  40. 21
  41. Lapouge, K., S. J. Smith, Y. Groemping, and K. Rittinger. 2002. Architecture of the p40-p47-p67phox complex in the resting state of the NADPH oxidase. A central role for p67phox. J. Biol. Chem. 277:10121-10128.[Abstract/Free Full Text]
  42. 22
  43. Lapouge, K., S. J. Smith, P. A. Walker, S. J. Gamblin, S. J. Smerdon, and K. Rittinger. 2000. Structure of the TPR domain of p67phox in complex with Rac.GTP. Mol. Cell 6:899-907.
  44. 23
  45. Leto, T. L., K. J. Lomax, B. D. Volpp, H. Nunoi, J. M. Sechler, W. M. Nauseef, R. A. Clark, J. I. Gallin, and H. L. Malech. 1990. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science 248:727-730.[Abstract/Free Full Text]
  46. 24
  47. Marty, C., D. D. Browning, and R. D. Ye. 2003. Identification of tetratricopeptide repeat 1 as an adaptor protein that interacts with heterotrimeric G proteins and the small GTPase Ras. Mol. Cell. Biol. 23:3847-3858.[Abstract/Free Full Text]
  48. 25
  49. Natochin, M., K. G. Gasimov, and N. O. Artemyev. 2001. Inhibition of GDP/GTP exchange on G alpha subunits by proteins containing G protein regulatory motifs. Biochemistry 40:5322-5328.[Medline]
  50. 26
  51. Nauseef, W. M., B. D. Volpp, S. McCormick, K. G. Leidal, and R. A. Clark. 1991. Assembly of the neutrophil respiratory burst oxidase. Protein kinase C promotes cytoskeletal and membrane association of cytosolic oxidase components. J. Biol. Chem. 266:5911-5917.[Abstract/Free Full Text]
  52. 27
  53. Nisimoto, Y., S. Motalebi, C. H. Han, and J. D. Lambeth. 1999. The p67(phox) activation domain regulates electron flow from NADPH to flavin in flavocytochrome b(558). J. Biol. Chem. 274:22999-23005.[Abstract/Free Full Text]
  54. 28
  55. O'Dowd, Y. M., J. El-Benna, A. Perianin, and P. Newsholme. 2004. Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst in human neutrophils by adrenaline: inhibition of phospholipase A2 activity but not p47phox phosphorylation and translocation. Biochem. Pharmacol. 67:183-190.[CrossRef][Medline]
  56. 29
  57. Parkos, C. A., R. A. Allen, C. G. Cochrane, and A. J. Jesaitis. 1987. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J. Clin. Investig. 80:732-742.[Medline]
  58. 30
  59. Pizzinat, N., A. Takesono, and S. M. Lanier. 2001. Identification of a truncated form of the G protein regulator AGS3 in heart that lacks the tetratricopeptide repeat domains. J. Biol. Chem. 276:16601-16610.[Abstract/Free Full Text]
  60. 31
  61. Price, M. O., L. C. McPhail, J. D. Lambeth, C. H. Han, U. G. Knaus, and M. C. Dinauer. 2002. Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system. Blood 99:2653-2661.[Abstract/Free Full Text]
  62. 32
  63. Quinn, M. T., and K. A. Gauss. 2004. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J. Leukoc. Biol. 76:760-781.[Abstract/Free Full Text]
  64. 33
  65. Quinn, M. T., C. A. Parkos, and A. J. Jesaitis. 1989. The lateral organization of components of the membrane skeleton and superoxide generation in the plasma membrane of stimulated human neutrophils. Biochim. Biophys. Acta 987:83-94.[Medline]
  66. 34
  67. Rasenick, M. M., P. J. Stein, and M. W. Bitensky. 1981. The regulatory subunit of adenylate cyclase interacts with cytoskeletal components. Nature 294:560-562.[CrossRef][Medline]
  68. 35
  69. Robinson, J. M., T. Ohira, and J. A. Badwey. 2004. Regulation of the NADPH-oxidase complex of phagocytic leukocytes. Recent insights from structural biology, molecular genetics, and microscopy. Histochem. Cell Biol. 122:293-304.[CrossRef][Medline]
  70. 36
  71. Ross, E. M., and T. M. Wilkie. 2000. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69:795-827.[CrossRef][Medline]
  72. 37
  73. Rotrosen, D., J. I. Gallin, A. M. Spiegel, and H. L. Malech. 1988. Subcellular localization of Gi alpha in human neutrophils. J. Biol. Chem. 263:10958-10964.[Abstract/Free Full Text]
  74. 38
  75. Rudolph, U., D. Koesling, K. D. Hinsch, R. Seifert, M. Bigalke, G. Schultz, and W. Rosenthal. 1989. G protein alpha-subunits in cytosolic and membranous fractions of human neutrophils. Mol. Cell. Endocrinol. 63:143-153.[CrossRef][Medline]
  76. 39
  77. Sarndahl, E., G. M. Bokoch, O. Stendahl, and T. Andersson. 1993. Stimulus-induced dissociation of alpha subunits of heterotrimeric GTP-binding proteins from the cytoskeleton of human neutrophils. Proc. Natl. Acad. Sci. USA 90:6552-6556.[Abstract/Free Full Text]
  78. 40
  79. Tsunawaki, S., S. Kagara, K. Yoshikawa, L. S. Yoshida, T. Kuratsuji, and H. Namiki. 1996. Involvement of p40phox in activation of phagocyte NADPH oxidase through association of its carboxyl-terminal, but not its amino-terminal, with p67phox. J. Exp. Med. 184:893-902.[Abstract/Free Full Text]
  80. 41
  81. Tsunawaki, S., and K. Yoshikawa. 2000. Relationships of p40(phox) with p67(phox) in the activation and expression of the human respiratory burst NADPH oxidase. J. Biochem. 128:777-783.[Abstract/Free Full Text]
  82. 42
  83. Volpp, B. D., W. M. Nauseef, J. E. Donelson, D. R. Moser, and R. A. Clark. 1989. Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. Proc. Natl. Acad. Sci. USA 86:7195-7199.[Abstract/Free Full Text]
  84. 43
  85. Wientjes, F. B., J. J. Hsuan, N. F. Totty, and A. W. Segal. 1993. p40phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem. J. 296:557-561.[Medline]
  86. 44
  87. Willard, F. S., R. J. Kimple, and D. P. Siderovski. 2004. Return of the GDI: the GoLoco motif in cell division. Annu. Rev. Biochem. 73:925-951.[CrossRef][Medline]
  88. 45
  89. Woodman, R. C., J. M. Ruedi, A. J. Jesaitis, N. Okamura, M. T. Quinn, R. M. Smith, J. T. Curnutte, and B. M. Babior. 1991. Respiratory burst oxidase and three of four oxidase-related polypeptides are associated with the cytoskeleton of human neutrophils. J. Clin. Investig. 87:1345-1351.[Medline]
  90. 46
  91. Ye, R. D., and F. Boulay. 1997. Structure and function of leukocyte chemoattractant receptors. Adv. Pharmacol. 39:221-289.[Medline]


Molecular and Cellular Biology, July 2006, p. 5190-5200, Vol. 26, No. 13
0270-7306/06/$08.00+0     doi:10.1128/MCB.01979-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marty, C.
Right arrow Articles by Ye, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marty, C.
Right arrow Articles by Ye, R. D.